{
  "approved_at_utc": null,
  "subreddit": "investing",
  "selftext": " \n\nI AM NOT A FINANCIAL ADVISOR\n\n**$TXMD** \\- TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Their products are designed to address the unique changes and challenges women experience through the various stages of their lives with a therapeutic focus in family planning, reproductive health, and menopause management. The company is committed to advancing the health of women and championing awareness of their healthcare issues.\n\n\\- On Feb. 11 they announced the pricing of its underwritten public offering of approximately 59.5 million shares of its common stock for gross proceeds of $110 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by TXMD. The offering is expected to close on February 16 (tomorrow). In addition, TXMD has granted the underwriter a 30-day option to purchase up to approximately 8.9 million additional shares of common stock.\n\n\\- Drug pipeline below:\n\n1. TXMD announces the submission of a New Drug Application for TX-001HR (Bijuva- a pill for the treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause) in December.\n2. Bijuva - The first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women.\n3. Segesterone Acetate - The first and only patient-controlled, procedure-free, long-acting, reversible prescription birth control product to provide a full year of protection from pregnancy.\n4. Yuvvexy - an applicator-free, vaginal, estradiol softgel capsule being proposed for the treatment of moderate-to-severe vaginal pain during sexual intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA) due to menopause.\n\n\\- Market Watch rates this stock as a buy, with a high stock price at $10, a median of $7, and a low of $3. It's current price is $1.92",
  "author_fullname": "t2_kl04nc6",
  "saved": false,
  "mod_reason_title": null,
  "gilded": 0,
  "clicked": false,
  "title": "Hey all, here is some DD on $TXMD",
  "link_flair_richtext": [],
  "subreddit_name_prefixed": "r/investing",
  "hidden": false,
  "pwls": 6,
  "link_flair_css_class": null,
  "downs": 0,
  "top_awarded_type": null,
  "hide_score": false,
  "name": "t3_lku7ah",
  "quarantine": false,
  "link_flair_text_color": "dark",
  "upvote_ratio": 0.95,
  "author_flair_background_color": null,
  "subreddit_type": "public",
  "ups": 41,
  "total_awards_received": 1,
  "media_embed": {},
  "author_flair_template_id": null,
  "is_original_content": false,
  "user_reports": [],
  "secure_media": null,
  "is_reddit_media_domain": false,
  "is_meta": false,
  "category": null,
  "secure_media_embed": {},
  "link_flair_text": null,
  "can_mod_post": false,
  "score": 41,
  "approved_by": null,
  "author_premium": false,
  "thumbnail": "",
  "edited": false,
  "author_flair_css_class": null,
  "author_flair_richtext": [],
  "gildings": {},
  "content_categories": null,
  "is_self": true,
  "mod_note": null,
  "created": 1613473363,
  "link_flair_type": "text",
  "wls": 6,
  "removed_by_category": null,
  "banned_by": null,
  "author_flair_type": "text",
  "domain": "self.investing",
  "allow_live_comments": false,
  "selftext_html": "<!-- SC_OFF --><div class=\"md\"><p>I AM NOT A FINANCIAL ADVISOR</p>\n\n<p><strong>$TXMD</strong> - TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Their products are designed to address the unique changes and challenges women experience through the various stages of their lives with a therapeutic focus in family planning, reproductive health, and menopause management. The company is committed to advancing the health of women and championing awareness of their healthcare issues.</p>\n\n<p>- On Feb. 11 they announced the pricing of its underwritten public offering of approximately 59.5 million shares of its common stock for gross proceeds of $110 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by TXMD. The offering is expected to close on February 16 (tomorrow). In addition, TXMD has granted the underwriter a 30-day option to purchase up to approximately 8.9 million additional shares of common stock.</p>\n\n<p>- Drug pipeline below:</p>\n\n<ol>\n<li>TXMD announces the submission of a New Drug Application for TX-001HR (Bijuva- a pill for the treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause) in December.</li>\n<li>Bijuva - The first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women.</li>\n<li>Segesterone Acetate - The first and only patient-controlled, procedure-free, long-acting, reversible prescription birth control product to provide a full year of protection from pregnancy.</li>\n<li>Yuvvexy - an applicator-free, vaginal, estradiol softgel capsule being proposed for the treatment of moderate-to-severe vaginal pain during sexual intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA) due to menopause.</li>\n</ol>\n\n<p>- Market Watch rates this stock as a buy, with a high stock price at $10, a median of $7, and a low of $3. It&#39;s current price is $1.92</p>\n</div><!-- SC_ON -->",
  "likes": null,
  "suggested_sort": null,
  "banned_at_utc": null,
  "view_count": null,
  "archived": false,
  "no_follow": false,
  "is_crosspostable": false,
  "pinned": false,
  "over_18": false,
  "awarders": [],
  "media_only": false,
  "can_gild": false,
  "spoiler": false,
  "locked": false,
  "author_flair_text": null,
  "treatment_tags": [],
  "visited": false,
  "removed_by": null,
  "num_reports": null,
  "distinguished": null,
  "subreddit_id": "t5_2qhhq",
  "mod_reason_by": null,
  "removal_reason": null,
  "link_flair_background_color": "",
  "id": "lku7ah",
  "is_robot_indexable": true,
  "report_reasons": null,
  "author": "PDWAMMO",
  "discussion_type": null,
  "num_comments": 18,
  "send_replies": true,
  "whitelist_status": "all_ads",
  "contest_mode": false,
  "mod_reports": [],
  "author_patreon_flair": false,
  "author_flair_text_color": null,
  "permalink": "/r/investing/comments/lku7ah/hey_all_here_is_some_dd_on_txmd/",
  "parent_whitelist_status": "all_ads",
  "stickied": false,
  "url": "https://www.reddit.com/r/investing/comments/lku7ah/hey_all_here_is_some_dd_on_txmd/",
  "subreddit_subscribers": 1690908,
  "created_utc": 1613482884,
  "num_crossposts": 0,
  "media": null,
  "is_video": false,
  "original_created_utc": 1613444563,
  "the_new_excerpt": "I AM NOT A FINANCIAL ADVISOR\n\n$TXMD - TherapeuticsMD, Inc. is an innovative, leading healthcare company,\nfocused on developing and commercializing novel products exclusively for women.\nTheir products are designed to address the unique changes and challenges women\nexperience through the variousâ€¦"
}